Low-barrier buprenorphine during the COVID-19 pandemic: A rapid transition to on-demand telemedicine with wide-ranging effects
Bradley M. Buchheit, Haven Wheelock, Abby Lee, Kimberly Brandt, Jessica Gregg
Topics & Concepts
TelemedicineHarm reductionTelepsychiatryTelehealthBuprenorphineMedicinePandemicMedical emergencyHealth careAgency (philosophy)AddictionEmergency departmentHarmNursingFamily medicinePublic healthCoronavirus disease 2019 (COVID-19)PsychiatryPsychologyPolitical scienceOpioidEpistemologyReceptorInternal medicineLawSocial psychologyInfectious disease (medical specialty)PhilosophyDiseasePathologyOpioid Use Disorder TreatmentDigital Mental Health InterventionsSubstance Abuse Treatment and Outcomes